Document:

EXHIBIT 10.21

                                STOCK OPTION PLAN

                                      For:

                                  GENEMAX CORP.

                                  GeneMax Corp.
                          435 Martin Street, Suite 2000
                        Blaine, Washington, U.S.A., 98230

<PAGE>

                                  GENEMAX CORP.

                                STOCK OPTION PLAN

     This stock option plan (the "Plan") is adopted in consideration of services
rendered and to be rendered by key personnel to GeneMax Corp., its subsidiaries
and affiliates.

1.   Definitions.

     The terms used in this Plan shall, unless otherwise indicated or required
by the particular context, have the following meanings:

     Board:                 The Board of Directors of GeneMax Corp.

     Common Stock:          The U.S. $0.001 par value common stock of GeneMax
                            Corp.

     Company:               GeneMax Corp., a corporation incorporated under the
                            laws of the State of Nevada, U.S.A., and any
                            successors in interest by merger, operation of law,
                            assignment or purchase of all or substantially all
                            of the property, assets or business of the Company.

     Date of Grant:         The date on which an Option (see hereinbelow) is
                            granted under the Plan.

     Fair Market Value:     The Fair Market Value of the Option Shares. Such
                            Fair Market Value as of any date shall be reasonably
                            determined by the Board; provided, however, that if
                            there is a public market for the Common Stock, the
                            Fair Market Value of the Option Shares as of any
                            date shall not be less than the closing price for
                            the Common Stock on the last trading day preceding
                            the date of grant; provided, further, that if the
                            Company's shares are not listed on any exchange the
                            Fair Market Value of such shares shall not be less
                            than the average of the means between the bid and
                            asked prices quoted on each such date by any two
                            independent persons or entities making a market for
                            the Common Stock, such persons or entities to be
                            selected by the Board. Fair Market Value shall be
                            determined without regard to any restriction other
                            than a restriction which, by its terms, will never
                            lapse.

<PAGE>

     Incentive Stock
     Option:                An Option as described in Section 9 hereinbelow
                            intended to qualify under section 422 of the United
                            States Internal Revenue Code of 1986, as amended.

     Key Person:            A person designated by the Board upon whose
                            judgment, initiative and efforts the Company or a
                            Related Company may rely, who shall include any
                            Director, Officer, employee or consultant of the
                            Company. A Key Person may include a corporation that
                            is wholly-owned and controlled by a Key Person who
                            is eligible for an Option grant, but in no other
                            case may the Company grant an option to a legal
                            entity other than an individual.

     Option:                The rights granted to a Key Person to purchase
                            Common Stock pursuant to the terms and conditions of
                            an Option Agreement (see hereinbelow).

     Option Agreement:      The written agreement (and any amendment or
                            supplement thereto) between the Company and a Key
                            Person designating the terms and conditions of an
                            Option.

     Option Shares:         The shares of Common Stock underlying an Option
                            granted to a Key Person.

     Optionee:              A Key Person who has been granted an Option.

     Related Company:       Any subsidiary or affiliate of the Company or of any
                            subsidiary of the Company. The determination of
                            whether a corporation is a Related Company shall be
                            made without regard to whether the entity or the
                            relationship between the entity and the Company now
                            exists or comes into existence hereafter.

2.   Purpose and scope.

     (a)  The purpose of the Plan is to advance the interests of the Company and
          its stockholders by affording Key Persons, upon whose judgment,
          initiative and efforts the Company may rely for the successful conduct
          of their businesses an opportunity for investment in the Company and
          the incentive advantages inherent in stock ownership in the Company.

<PAGE>

     (b)  This Plan authorizes the Board to grant Options to purchase shares of
          Common Stock to Key Persons selected by the Board while considering
          criteria such as employment position or other relationship with the
          Company, duties and responsibilities, ability, productivity, length of
          service or association, morale, interest in the Company,
          recommendations by supervisors and other matters.

3.   Administration of the Plan.

     The Plan shall be administered by the Board. The Board shall have the
authority granted to it under this section and under each other section of the
Plan.

     In accordance with and subject to the provisions of the Plan, the Board is
hereby authorized to provide for the granting, vesting, exercise and method of
exercise of any Options all on such terms (which may vary between Options and
Optionees granted from time to time) as the Board shall determine. In addition,
and without limiting the generality of the foregoing, the Board shall select the
Optionees and shall determine: (i) the number of shares of Common Stock to be
subject to each Option, however, in no event may the maximum number of shares
reserved for any one individual exceed 15% of the issued and outstanding share
capital of the Company; (ii) the time at which each Option is to be granted;
(iii) the purchase price for the Option Shares; (iv) the Option period; and (v)
the manner in which the Option becomes exercisable or terminated. In addition,
the Board shall fix such other terms of each Option as it may deem necessary or
desirable. The Board may determine the form of Option Agreement to evidence each
Option.

     The Board from time to time may adopt such rules and regulations for
carrying out the purposes of the Plan as it may deem proper and in the best
interests of the Company subject to the rules and policies of any exchange or
over-the-counter market which is applicable to the Company.

     The Board may from time to time make such changes in and additions to the
Plan as it may deem proper, subject to the prior approval of any exchange or
over-the-counter market which is applicable to the Company, and in the best
interests of the Company; provided, however, that no such change or addition
shall impair any Option previously granted under the Plan. If the shares are not
listed on any exchange, then such approval is not necessary.

     Each determination, interpretation or other action made or taken by the
Board shall be final, conclusive and binding on all persons, including without
limitation, the Company, the stockholders, directors, officers and employees of
the Company and the Related Companies, and the Optionees and their respective
successors in interest.

<PAGE>

4.   The Common Stock.

     Save and except as may be determined by the Board at a duly constituted
meeting of the Board as set forth hereinbelow, the Board is presently authorized
to appropriate, grant Options, issue and sell for the purposes of the Plan, a
total number of shares of the Company's Common Stock not to exceed 3,500,000, or
the number and kind of shares of Common Stock or other securities which in
accordance with Section 10 shall be substituted for the shares or into which
such shares shall be adjusted. Save and except as may otherwise be determined by
the disinterested approval of the shareholders of the Company at any duly called
meeting of the shareholders of the Company, at any duly constituted Board
meeting the Board may determine that the total number of shares of the Company's
Common Stock which may be reserved for issuance for Options granted and to be
granted under this Plan, from time to time, may be to the maximum extent of up
to 100% of the Company's issued and outstanding Common Stock as at the date of
any such meeting of the Board. In this regard, and subject to the prior
disinterested approval of the shareholders of the Company at any duly called
meeting of the shareholders of the Company, the total number of shares of the
Company's Common Stock which may be reserved for issuance for Options granted
and to be granted under this Plan, from time to time, may be increased to
greater than 100% of the Company's issued and outstanding Common Stock as at the
date of notice of any such meeting of the shareholders of the Company whereat
such disinterested shareholders' approval is sought and obtained by the Company.
All or any unissued shares subject to an Option that for any reason expires or
otherwise terminates may again be made subject to Options under the Plan.

5.   Eligibility.

     Options will be granted only to Key Persons. Key Persons may hold more than
one Option under the Plan and may hold Options under the Plan and options
granted pursuant to other plans or otherwise.

6.   Option Price and number of Option Shares.

     The Board shall, at the time an Option is granted under this Plan, fix and
determine the exercise price at which Option Shares may be acquired upon the
exercise of such Option; provided, however, that any such exercise price shall
not be less than that, from time to time, permitted under the rules and policies
of any exchange or over-the-counter market which is applicable to the Company.

     The number of Option Shares that may be acquired under an Option granted to
an Optionee under this Plan shall be determined by the Board as at the time the
Option is granted; provided, however, that the aggregate number of Option Shares
reserved for issuance to any one Optionee under this Plan, or any other plan of
the Company, shall not exceed 15% of the total number of issued and outstanding
Common Stock of the Company.

<PAGE>

7.   Duration, vesting and exercise of Options.

     (a)  The option period shall commence on the Date of Grant and shall be up
          to 10 years in length subject to the limitations in this Section 7 and
          the Option Agreement.

     (b)  During the lifetime of the Optionee the Option shall be exercisable
          only by the Optionee. Subject to the limitations in paragraph (a)
          hereinabove, any Option held by an Optionee at the time of his death
          may be exercised by his estate within one year of his death or such
          longer period as the Board may determine.

     (c)  The Board may determine whether an Option shall be exercisable at any
          time during the option period as provided in paragraph (a) of this
          Section 7 or whether the Option shall be exercisable in installments
          or by vesting only. If the Board determines the latter it shall
          determine the number of installments or vesting provisions and the
          percentage of the Option exercisable at each installment or vesting
          date. In addition, all such installments or vesting shall be
          cumulative. In this regard the Company will be subject, at all times,
          to any rules and policies of any exchange or over-the-counter market
          which is applicable to the Company and respecting any such required
          installment or vesting provisions for certain or all Optionees.

     (d)  In the case of an Optionee who is a director or officer of the Company
          or a Related Company, if, for any reason (other than death or removal
          by the Company or a Related Company), the Optionee ceases to serve in
          that position for either the Company or a Related Company, any option
          held by the Optionee at the time such position ceases or terminates
          may, at the sole discretion of the Board, be exercised within up to 90
          calendar days after the effective date that his position ceases or
          terminates (subject to the limitations at paragraph (a) hereinabove),
          but only to the extent that the option was exercisable according to
          its terms on the date the Optionee's position ceased or terminated.
          After such 90-day period any unexercised portion of an Option shall
          expire.

     (e)  In the case of an Optionee who is an employee or consultant of the
          Company or a Related Company, if, for any reason (other than death or
          termination for cause by the Company or a Related Company), the
          Optionee ceases to be employed by either the Company or a Related
          Company, any option held by the Optionee at the time his employment
          ceases or terminates may, at the sole discretion of the Board, be
          exercised within up to 60 calendar days (or up to 30 calendar days

<PAGE>

          where the Optionee provided only investor relations services to the
          Company or a Related Company) after the effective date that his
          employment ceased or terminated (that being up to 60 calendar days (or
          up to 30 calendar days) from the date that, having previously provided
          to or received from the Company a notice of such cessation or
          termination, as the case may be, the cessation or termination becomes
          effective; and subject to the limitations at paragraph (a)
          hereinabove), but only to the extent that the option was exercisable
          according to its terms on the date the Optionee's employment ceased or
          terminated. After such 60-day (or 30-day) period any unexercised
          portion of an Option shall expire.

     (f)  In the case of an Optionee who is an employee or consultant of the
          Company or a Related Company, if the Optionee's employment by the
          Company or a Related Company ceases due to the Company's termination
          of such Optionee's employment for cause, any unexercised portion of
          any Option held by the Optionee shall immediately expire. For this
          purpose "cause" shall mean conviction of a felony or continued
          failure, after notice, by the Optionee to perform fully and adequately
          the Optionee's duties.

     (g)  Neither the selection of any Key Person as an Optionee nor the
          granting of an Option to any Optionee under this Plan shall confer
          upon the Optionee any right to continue as a director, officer,
          employee or consultant of the Company or a Related Company, as the
          case may be, or be construed as a guarantee that the Optionee will
          continue as a director, officer, employee or consultant of the Company
          or a Related Company, as the case may be.

     (h)  Each Option shall be exercised in whole or in part by delivering to
          the office of the Treasurer of the Company written notice of the
          number of shares with respect to which the Option is to be exercised
          and by paying in full the purchase price for the Option Shares
          purchased as set forth in Section 8.

8.   Payment for Option Shares.

     In the case of all Option exercises, the purchase price shall be paid in
cash or certified funds upon exercise of the Option.

<PAGE>

9.   Incentive stock Options.

     (a)  The Board may, from time to time, and subject to the provisions of
          this Plan and such other terms and conditions as the Board may
          prescribe, grant to any Key Person who is an employee eligible to
          receive Options one or more Incentive Stock Options to purchase the
          number of shares of Common Stock allotted by the Board.

     (b)  The Option price per share of Common Stock deliverable upon the
          exercise of an Incentive Stock Option shall be no less than the Fair
          Market Value of a share of Common Stock on the Date of Grant of the
          Incentive Stock Option.

     (c)  The Option term of each Incentive Stock Option shall be determined by
          the Board and shall be set forth in the Option Agreement, provided
          that the Option term shall commence no sooner than from the Date of
          Grant and shall terminate no later than 10 years from the Date of
          Grant and shall be subject to possible early termination as set forth
          in Section 7 hereinabove.

10.  Changes in Common Stock, adjustments, etc.

     In the event that each of the outstanding shares of Common Stock (other
than shares held by dissenting stockholders which are not changed or exchanged)
should be changed into, or exchanged for, a different number or kind of shares
of stock or other securities of the Company, or, if further changes or exchanges
of any stock or other securities into which the Common Stock shall have been
changed, or for which it shall have been exchanged, shall be made (whether by
reason of merger, consolidation, reorganization, recapitalization, stock
dividends, reclassification, split-up, combination of shares or otherwise), then
there shall be substituted for each share of Common Stock that is subject to the
Plan, the number and kind of shares of stock or other securities into which each
outstanding share of Common Stock (other than shares held by dissenting
stockholders which are not changed or exchanged) shall be so changed or for
which each outstanding share of Common Stock (other than shares held by
dissenting stockholders) shall be so changed or for which each such share shall
be exchanged. Any securities so substituted shall be subject to similar
successive adjustments.

     In the event of any such changes or exchanges, the Board shall determine
whether, in order to prevent dilution or enlargement of rights, an adjustment
should be made in the number, kind, or option price of the shares or other
securities then subject to an Option or Options granted pursuant to the Plan and
the Board shall make any such adjustment, and such adjustments shall be made and
shall be effective and binding for all purposes of the Plan.

<PAGE>

11.  Relationship of employment.

     Nothing contained in the Plan, or in any Option granted pursuant to the
Plan, shall confer upon any Optionee any right with respect to employment by the
Company, or interfere in any way with the right of the Company to terminate the
Optionee's employment or services at any time.

12.  Non-transferability of Option.

     No Option granted under the Plan shall be transferable by the Optionee,
either voluntarily or involuntarily, except by will or the laws of descent and
distribution, and any attempt to do so shall be null and void.

13.  Rights as a stockholder.

     No person shall have any rights as a stockholder with respect to any share
covered by an Option until that person shall become the holder of record of such
share and, except as provided in Section 10, no adjustments shall be made for
dividends or other distributions or other rights as to which there is an earlier
record date.

14.  Securities laws requirements.

     No Option Shares shall be issued unless and until, in the opinion of the
Company, any applicable registration requirements of the United States
Securities Act of 1933, as amended, any applicable listing requirements of any
securities exchange on which stock of the same class is then listed, and any
other requirements of law or of any regulatory bodies having jurisdiction over
such issuance and delivery, have been fully complied with. Each Option and each
Option Share certificate may be imprinted with legends reflecting federal and
state securities laws restrictions and conditions, and the Company may comply
therewith and issue "stop transfer" instructions to its transfer agent and
registrar in good faith without liability.

15.  Disposition of Option Shares.

     Each Optionee, as a condition of exercise, shall represent, warrant and
agree, in a form of written certificate approved by the Company, as follows: (i)
that all Option Shares are being acquired solely for his own account and not on
behalf of any other person or entity; (ii) that no Option Shares will be sold or
otherwise distributed in violation of the United States Securities Act of 1933,
as amended, or any other applicable federal or state securities laws; (iii) that
if he is subject to reporting requirements under Section 16(a) of the United
States Securities Exchange Act of 1934, as amended, he will (a) furnish the
Company with a copy of each Form 4 filed by him and (b) timely file all reports
required under the federal securities laws; and (iv) that he will report all
sales of Option Shares to the Company in writing on a form prescribed by the
Company.

<PAGE>

16.  Effective date of Plan; termination date of Plan.

     The Plan shall be deemed effective as of September 30, 2002. The Plan shall
terminate at midnight on September 30, 2012 except as to Options previously
granted and outstanding under the Plan at the time. No Options shall be granted
after the date on which the Plan terminates. The Plan may be abandoned or
terminated at any earlier time by the Board, except with respect to any Options
then outstanding under the Plan.

17.  Other provisions.

     The following provisions are also in effect under the Plan:

     (a)  the use of a masculine gender in the Plan shall also include within
          its meaning the feminine, and the singular may include the plural, and
          the plural may include the singular, unless the context clearly
          indicates to the contrary;

     (b)  any expenses of administering the Plan shall be borne by the Company;

     (c)  this Plan shall be construed to be in addition to any and all other
          compensation plans or programs. The adoption of the Plan by the Board
          shall not be construed as creating any limitations on the power or
          authority of the Board to adopt such other additional incentive or
          other compensation arrangements as the Board may deem necessary or
          desirable; and

     (d)  the validity, construction, interpretation, administration and effect
          of the Plan and of its rules and regulations, and the rights of any
          and all personnel having or claiming to have an interest therein or
          thereunder shall be governed by and determined exclusively and solely
          in accordance with the laws of the State of Nevada, U.S.A.

     This Plan is dated and made effective as approved by the shareholders of
the Company on this 30th day of September, 2002.

<PAGE>

                      BY ORDER OF THE BOARD OF DIRECTORS OF
                                  GENEMAX CORP.
                                      Per:

                              "Ronald L. Handford"

                               Ronald L. Handford
                            President and a Director
                                   __________novakemploymentagmt

                              EMPLOYMENT AGREEMENT

        THIS EMPLOYMENT AGREEMENT ("this Agreement") is made and entered into as of
the 1st of June 2002 by and between Surgical Safety Products, Inc., a New York
corporation (the "Company"), and Timothy S. Novak, an individual ("Novak", "he",
"his", or "him") (referred to hereinafter, each as a "Party", and collectively
as the "Parties").

        WHEREAS, the Company desires to employ Novak as the Company's Chief
Executive Officer (CEO) to perform the duties as set forth in this Agreement;
and

        WHEREAS, Novak is willing to accept such employment upon the terms and
conditions set forth in this Agreement, and further conditioned upon the
Company's continued and faithful performance of its duties and obligations under
this Agreement;

        NOW, THEREFORE, in consideration of the foregoing, the promises contained
herein, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the Parties, intending to be legally bound,
agree as follows:

        1. Effective Date and Term:

        1.01 Term and Effective Date: The term of Novak's employment shall commence
on the date hereof (the "Effective Date") and shall, continue until terminated
pursuant to the provisions for termination as hereinafter provided in ss.5 of
this Agreement.

        2. Novak's Duties and Authority

        2.01 Duties: Novak shall be assigned and perform those duties of the type,
nature and dignity normally assigned to the CEO of an entity similar in type and
nature to that of the Company. Novak shall devote his full time (excepting
periods of vacation, illness, disability, and Permitted Activities as
hereinafter defined), services and abilities to the Company and its accounting
and financial affairs and requirements, during the normal business hours of the
Company.

        2.02 Authority: Novak shall participate in and manage all decisions
regarding the Company's operational, administrative, business, and financial
affairs of the Company. Novak shall be responsible to, and shall report directly
to Company Board of Directors. Novak shall be kept advised and timely informed
of information, issues, or problems relevant to operational, administrative,
business, and financial affairs of the Company.

                                       1

        2.03 Support: Novak shall be afforded office space, computer support
(including legal and corporate data bases), reference materials, subscriptions,
Continuing professional education ("CPE") and other materials and support
necessary to perform his duties and responsibilities, and maintain professional
proficiency and skill. Novak shall be provided reasonable administrative and
in-house professional support, including the right to engage, at his discretion,
the services and advice of outside auditors and accountants to assist him in the
performance of his duties, including providing accounting and auditing expertise
and advice in matters and areas in which he, in his discretion, feels desirable,
and he shall have the authority and discretion to terminate the services of any
such outside support.

        3. Compensation

        3.01 Base Salary: Novak shall be paid an annual base salary ("Base Salary")
of One Hundred-Fifty Thousand ($150,000). Dollars, payable in no less frequent
installments than twice monthly. Upon the first anniversary form the Effective
Date his Base Salary shall be increased by an amount equal to not less than ten
(20%) percent and shall be paid on the same basis and frequency as provided
above; and over that paid payable for the immediately preceding term, or in such
greater amount as the Company and Novak shall agree.

        3.02 Discretionary Bonus Compensation: In the discretion of the Board of
Directors, and based upon his annual performance evaluation Novak may be awarded
cash bonuses, in addition to his Base Salary, the amount of said bonus to be
based upon the extent to which the Company's gross revenues have increased
during the period, up to a maximum of 100% of Novak's Base Salary for the period
in which the bonus is awarded ("Discretionary Bonus"). The Discretionary Bonus
shall be in addition to, not in lieu of, bonuses, awards, and benefits given or
received by Novak underss.3.03 andss.4 of this Agreement.

        3.03 Withholding of Taxes: The Company shall cause to be withheld from
Novak's taxable compensation or benefits, and remitted to the appropriate taxing
authority, all federal, state and local taxes as shall be required to be
withheld by law, regulation or ruling.

        4. Benefits and reimbursement

        4.01 Business Related Benefits, Payments and Reimbursements: Novak shall
receive the following benefits in addition to the compensation provided inss.3
of this Agreement: i) fully paid family health insurance under the company group
plan; ii) fully paid family dental insurance under company group plan; iii)
payment or reimbursement of all business related use of telephone (including
cellular), home fax, and other business related productivity devices; v) payment
or reimbursement of all business related travel expenses; and iv) fully
compensated leave and vacation at his discretion reasonably exercised in
recognition of his duties and performance requirements.

                                       2

        4.02 Fringe Benefits: Novak shall be entitled to receive all fringe
benefits afforded to, and upon the same basis as, the highest executives of the
Company, including, but not limited to: participation in the Company's 401k
Plan; life insurance (including any tax sheltered annuity plan "split dollar"
plan, and executive term life coverage available); awards under all stock
option, bonus, and incentive plans of the Company; Company paid health and
reimbursement (medical and dental) coverage for him and his spouse; short term
sick leave and long term disability benefits coverage; and accident insurance
coverage.

        4.03 Rights Regarding Stock. (a) Company stock issued or acquired by Novak,
or, if applicable, Company stock acquired through the exercise of any option to
purchase such stock shall i) be issued to Novak without restriction on his
immediate sale or disposition of such stock; ii) shall be fully registered, or
if no registration statement has yet been made effective, will have "Piggy-Back"
rights whereby Novak may elect, and the Company shall give Novak adequate notice
for him to make such election, to have such shares included on the next
registration statement filed by the Company after such payment or grant at the
Company's sole expense; iii) shall not, without Novak's written consent, be
subject to any "Lock-up", or "Stand-still" agreement ; provided however, that if
such an agreement is required by an underwriter of, and as a condition of, a
public offering of such stock, then Novak may, in his discretion, "put" such
number of shares to the Company as he shall elect, at such price per share as
may be agreed to by the Parties, and the Company shall, as a condition precedent
to Novak's consent, pay Novak in full for such shares and Novak shall thereupon
give his written consent to and shall enter into such agreement.

        (b) With reference to any options to purchase Company Stock which may be
granted to Novak, should at anytime: i) the Company elect to make a public
offering of its stock; or ii) should there occur a "change in control" of the
Company whereby (and which shall, for the purposes of this Agreement be defined
as) any "Person" (as that term is defined or used for purposes ofss.13(d) or
14(d) of the Exchange Act acquires "Beneficial Ownership"(within the meaning of
Rule 13d-3 under the Exchange Act)) voting securities of the Company ("Voting
Securities") representing 20% or more of the combined voting power of the
Company's then outstanding Voting Securities; or iii) should there occur w) an
acquisition of 30% or more of the Company's assets, x) a merger, y) a
consolidation, or z) a reorganization, involving the Company; then upon the
occurrence of any of the aforesaid any options still unvested at the time of
such occurrence shall become immediately vested and exercisable.

                                       3

        5. Termination

        5.01 Termination by the Company for Cause: (a) The Company may terminate
this Agreement for "Cause" by giving Novak thirty (30) days written notice.
"Cause shall be defined as and shall be only upon the following conditions:

        1) conviction of a criminal offense, other than a traffic related offense;
        2) gross disregard or intentional misconduct in the performance of his
           duties as set out inss.2, including engaging in activities for profit outside of
           his duties for the Company, except for Permitted Activities;
        3) any intentional act which materially damages the Company's
           reputation; and
        4) inability to substantially perform his duties and responsibilities by reason of
           physical or mental disability, which shall be determined, at the Company's
           expense, by the opinion of at least two of a panel of three licensed
           physicians, two of whom may be selected by Novak, one or more of whom must
           specialize in the area of Novak's allegedly disabling condition.

        In the event of termination of this Agreement for Cause under 1), 2), or 3)
of thisss.5.01(a), Novak shall be entitled to no further salaried compensation
or bonuses after the effective date of termination, except as provided in
ss.5.04. Such termination may be made effective immediately upon the Company's
payment in full upon such effective date of Novak's salaried compensation under
this Agreement which would become due over the thirty (30) day notice period,
together with such other sums as provided underss.5.04.

        In the event that this Agreement is terminated for Cause as specified under
4) of thisss.5.01(a), Novak shall receive Termination Payments (as defined
inss.5.02(b)) for 90 days from the effective date of termination.

        5.02 Involuntary Termination: (a) The Company shall be entitled to
terminate Novak's employment for any reason other than Cause only by giving him
ninety (90) days written notice ("Involuntary Termination"). The Company shall
have the right to make such termination effective at any time prior to the
expiration of the 90-day notice period by paying Novak immediately upon the
giving of such notice of termination all compensation and benefits due and to
become due under this Agreement for the 90-day notice period, and such portion,
if any, of the bonus compensation underss.ss.3.02 and 3.03 as shall be due but
unpaid to him as of the expiration of the 90-day period.

                                       4

        (b) If the Company terminates this Agreement for any reason other than
Cause then in addition to the payments provided in (a) of thisss.5.02, the
Company shall pay and provide to Novak, all of the compensation provided
underss.3.01 andss.3.02 of this Agreement, at the rate and level as shall then
be in effect; plus the insurance fringe benefits provided underss.4.02
(collectively, the "Termination Payments") and shall continue to pay and provide
to him following the effective date upon which such termination shall occur, for
(i) 6 months if termination occur prior to six months from the Effective Date,
or (ii) 3 months should the termination occur thereafter ("Post Termination
Period").

        Termination by Novak: (a) Novak may terminate his employment with the
Company, at any time, at his discretion ("Resign") upon the giving of written
notice to the Company. In the event that Novak Resigns for other than Good
Reason (as hereinafter defined), he shall receive no Termination Payments, or
any other or further compensation except as provided inss.5.04 of this
Agreement. Provided, however, that should Novak Resign for Good Reason (as
hereinafter defined) he shall be entitled to receive, and shall receive, as
provided inss.5.02, Termination Payments for 6 months following the effective
date upon which he Resigns. "Good Reason" shall be defined, and shall be deemed
to exist or occur for any one of the following: i) if Novak's position,
day-to-day duties, or responsibilities with the Company are diminished or
otherwise changed or modified without his consent; ii) should his working
relationship or treatment by the Company's senior management be degraded, or
should he be required or demanded to take or commit an act or omission which
Novak deems, in his reasonable discretion, to be illegal or unethical; iii)
should for any reason his then current cash or stock compensation be reduced, or
his benefits and perquisites underss.4 be materially reduced, or any of the
foregoing not be timely paid or provided; iv) if there occurs or exists a change
in the management control of the Company or in its Board of Directors; v) if
their occurs a "change in control" as defined inss.3.03(a); vi) if the Company
relocates Novak's daily work-place to a location outside of a 150-mile radius of
Sarasota, Florida, except for reasonably required and occasional travel on the
Company's business; or vii) if the Company fails or refuses to timely provide or
perform any of its duties, obligations, commitments, or undertakings under this
Agreement.

        (b) If Novak Resigns his employment for Good Reason then in addition to the
payments provided in ofss.5.02(a), the Company shall pay and provide to Novak,
and shall continue to pay and provide to him Benefits for the Post Termination
Period.

        5.04 Effect of Termination Under Certain Circumstances On Unvested Option
Grants: In the event that Novak's employment shall terminate either: i)
involuntarily for Cause underss.5.01(a), 4); or ii) involuntarily underss.5.02;
or iii) because Novak Resigns with Good Reason underss.5.03, all stock options
which are yet unvested as of the effective date of such termination shall upon
such effective date become immediately vested and exercisable.

                                       5

        5.05 Unpaid Compensation: In addition to and notwithstanding any other
payments provided under this Agreement, including thisss.5, upon his
termination, regardless of the reason or cause therefor, Novak shall be paid any
and all earned or accrued but unpaid benefits and compensation including,
without limitation, reimbursement for incurred expenses, and any bonus
compensation earned but unpaid as of the effective date of such termination.

        6. Miscellaneous Provisions

        6.01 Notices: Notices required or permitted to be given under this
Agreement shall be sufficient if in writing and delivered by hand, or sent by
certified or registered mail--return receipt requested and postage prepaid, to
the Parties at their respective addresses as follows, or to such other recipient
as the Parties, or either of them, shall designate in writing to the other:

              To the Company:            Surgical Safety Products, Inc.
                                         Attn: Board of Directors
                                         One Sarasota Tower
                                         2 North Tamiami Trail
                                         Suite 608
                                         Sarasota, FL 34236
                                         (941)953-9848

              To Mr. Novak:              Timothy S. Novak
                                         7216 River Club Blvd
                                         Bradenton, FL  34202
                                         (941) 358-5646

        6.02 Non-waiver of Breach: The waiver by a Party of a breach of any
provision(s) of this Agreement shall neither be deemed, operate, nor be
construed as a waiver by either Party of any other, or subsequent, breach.

        6.04 Amendment: This Agreement may neither be amended nor modified except
by a writing executed by both of the Parties.

        6.05 Governing Law: This Agreement shall be governed by the laws of the
Commonwealth of Virginia.

        6.06 Separability: Should any provision, condition, or term of this
Agreement, or part thereof, be deemed or determined to be illegal, prohibited,
or null and void, it shall not effect the enforceability of any other of the
remaining provisions, conditions, or terms hereof, and the remaining provisions,
conditions, and terms shall be enforced as though the provision, condition, or
term so deemed or determined had not been contained herein.

                                       6

        6.07 Arbitration: The Parties agree that disputes, controversies, or claims
arising out of or related to this Agreement, which can not be settled by
agreement of the Parties, including a claim of breach thereof, and including the
issue of arbitrability, shall be determined by a single arbitrator appointed by
agreement of the Parties, or if unable to agree, then by the American
Arbitration Association ("the AAA"). The arbitration shall be conducted in
accordance with the then current Commercial Arbitration Rules of the AAA, or
such other rules as to which the Parties may agree. The Parties shall each bear
their respective costs and expenses of the arbitration. The decision of the
arbitrator shall be final and binding upon the Parties, and a fully enforceable
judgment may be entered upon the award in any court of competent jurisdiction.

        6.08 Successors and Assigns: (a) This Agreement shall be binding upon and
shall inure to the benefit of the Company and its successors and assigns, and
the Company shall require any successor or assign to expressly assume and agree
to perform this Agreement in the same manner and to the same extent that the
Company would be required to perform it if there had been no such succession or
assignment. The term "successors and assigns" shall mean a corporation or other
entity, or individual acquiring all or substantially all the assets and business
of the Company whether by operation of law or otherwise; and the term "the
Company", as used herein, shall be deemed to include such successors and
assigns.

        (b) Neither this Agreement nor any right or interest hereunder shall be
assignable or transferable by Novak, his beneficiaries or legal representatives,
except by will or the applicable laws of descent and distribution. This
Agreement shall inure to the benefit of and be enforceable by Novak's personal
representative.

        6.09 Indemnification: The Company shall indemnify Novak and hold him
harmless from any and all suits, claims, demands, and liability of any and every
kind and nature ("Proceeding"), against all Expenses (as hereinafter defined)
incurred or suffered by him in connection therewith, including those to which he
is threatened to be made a party, arising out of or related, in whole or in
part, to acts or omissions in connection with, or within the scope of, his
employment or activities with the Company, provided that such act or omission
was taken or performed, or omitted to be taken or performed, in good faith by
Novak, and in a manner which he reasonably believed to be not opposed to the
Company's best interest. As used in this Agreement, the term "Expenses" shall
include, without limitation, damages, losses, judgments, liabilities, fines,
penalties, excise taxes, settlements, and costs, attorneys' fees, accountants'
fees, investigations, and any expenses of establishing a right to
indemnification under this Agreement. Expenses incurred by Novak in connection
with any Proceeding shall be paid by the Company in advance upon request of
Novak that the Company pay such Expenses. Such indemnification obligation shall
continue as to Novak even if he has ceased to be an officer, director, or agent,
or is no longer employed by the Company and shall inure to the benefit of his
heirs, executors and administrators. The company shall not, without Novak's
prior written consent, settle any action or claim in any manner that would not
include a full and unconditional release of Novak. Neither the Company nor Novak
will unreasonably withhold or delay their consent to any proposed settlement.
The Company shall provide Novak coverage equal to that afforded the highest

                                       7

executive of the Company under the directors' and officers' liability policy
currently and from time to time in force, or, if none, a policy commercially
acceptable to Novak; but in no event shall Novak be obligated or required to
satisfy or contribute to any self-insured retention, deductible or similar
provision under such policies, as those terms are used in their commercial
meaning within the insurance industry.

        6.10 Entire Understanding: This Agreement represents the full, complete and
entire understanding of the Parties with respect to the matters contained in
this Agreement, and there are no other contracts, representations,
understandings, agreements, undertakings, conditions precedent or subsequent, or
other obligations of any kind or nature, expressed or implied, written or oral,
which are not set forth in, or have been or shall be made or entered into
pursuant to, this Agreement.

        IN WITNESS WHEREOF, the Parties have executed this Agreement, the Company
acting by and through its duly authorized officer, as of the date first above
written.

                                           Surgical Safety Products, Inc.
                                           ("the Company")

                                           By:/s/ R. Paul Gray
                                              Name: R. Paul Gray
                                              Title:  CFO & Executive Vice-President
                                              Representing the Board of Directors

                                           By:/s/ Timothy Novak
                                              Name: Timothy S. Novak
                                              Title:  Chairman and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}]]